0001640334-16-001063.txt : 20160513 0001640334-16-001063.hdr.sgml : 20160513 20160513133406 ACCESSION NUMBER: 0001640334-16-001063 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 35 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EOS INC. CENTRAL INDEX KEY: 0001651958 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 300873246 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-206853 FILM NUMBER: 161647370 BUSINESS ADDRESS: STREET 1: ROOM 519, 5F., NO.372, STREET 2: LINSEN N. RD., ZHONGSHAN DIST. CITY: TAIPEI CITY STATE: F5 ZIP: 104 BUSINESS PHONE: 8862-2568-3278 MAIL ADDRESS: STREET 1: ROOM 519, 5F., NO.372, STREET 2: LINSEN N. RD., ZHONGSHAN DIST. CITY: TAIPEI CITY STATE: F5 ZIP: 104 10-Q 1 2016mar31-eos_10q.htm FORM 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q
 
(Mark One)
 
 
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
FOR THE QUARTERLY PERIOD ENDED  March 31, 2016
 
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT
 
FOR THE TRANSITION PERIOD FROM __________ TO __________
 
COMMISSION FILE NUMBER 333-206853
 
EOS Inc.
(Exact name of registrant as specified in its charter)

Nevada
(State or other jurisdiction of incorporation or organization)
30-0873246
(I.R.S. Employer Identification No.)
 
Room 519, 5F., No. 372, Linsen N. Road,
Zhongshan District,
Taipei City 104, Taiwan (R.O.C.)
 (Address of principal executive offices, Zip Code)

011-886-2-25683278
(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Copies to:
Thomas E. Stepp, Jr.
Stepp Law Corporation
15707 Rockfield Boulevard, Suite 101
Irvine, California 92618
Phone: (949) 660-9700 ext. 124
Fax: (949) 660-9010


Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x No

 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,”  “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  Accelerated filer o
Non-accelerated filer o Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No 
 
The number of shares of registrant’s common stock outstanding, as of May 10, 2016, is 64,122,997.

TABLE OF CONTENTS
 
 
 
Page
 
 
 
 
 
 
Item 1.       Financial Statements
 
 
1
 
 
 
9
 
 
 
10
 
Item 4.       Controls and Procedures
   
10
 
 
 
 
   
 
 
 
 
 
Item 1.       Legal Proceedings
 
 
10
 
Item 1A.    Risk Factors     10  
 
 
10
 
 
 
10
 
Item 4.       Mine Safety Disclosures
 
 
10
 
Item 5.       Other Information
 
 
10
 
Item 6.       Exhibits
 
 
11
 
 
 
 
 
 
 
 
12
 
 
 
PART I – FINANCIAL INFORMATION

Item 1.  Financial Statements
 
CONTENTS
    Page  
 
2
 
 
3
   
 
4
   
 
5 - 8
 
 

 
 
EOS INC
BALANCE SHEET
 
   
March 31,
2016
   
December 31,
2015
 
   
(Unaudited)
       
Assets
       
Current Assets
           
Cash and cash equivalents
 
$
90,024
   
$
54,132
 
Total current assets
   
90,024
     
54,132
 
                 
Total Assets
 
$
90,024
   
$
54,132
 
                 
Liabilities and Stockholders’ Deficit
         
                 
Current Liabilities
               
Accrued expenses
   
28,138
     
-
 
Due to related parties
   
185,912
     
150,000
 
Total current liabilities
   
214,050
     
150,000
 
                 
                 
Stockholders' Deficit
               
Common stock, $0.001 par value; 750,000,000 shares authorized, 64,122,997 and 54,122,997 shares issued and outstanding, respectively
   
64,123
     
54,123
 
Additional paid-in capital
   
90,000
     
-
 
Accumulated deficits
   
(278,149
)
   
(149,991
)
Total stockholders' deficit
   
(24,026
)
   
(95,868
)
                 
Total Liabilities and Stockholders' Deficit
 
$
90,024
   
$
54,132
 
 
 
The accompanying notes to financial statements are an integral part of these statements.
EOS INC.
STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 2016
(UNAUDITED)
 
   
Three Months Ended March 31, 2016
 
Net revenue
 
$
-
 
         
General and administrative expenses
   
128,158
 
Loss from operations
   
(128,158
)
         
Loss before income taxes
   
(128,158
)
         
Provision for income taxes expense
   
-
 
Net loss
   
(128,158
)
         
Weighted average number of shares outstanding:
       
Basic and diluted
   
58,188,931
 
         
Net loss per share:
       
Basic and diluted
 
$
(0.00
)
 
 
The accompanying notes to financial statements are an integral part of these statements.
EOS INC.
STATEMENT OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2016
(UNAUDITED)
 
     
Three Months Ended March 31, 2016
 
Cash Flows from Operating Activities
     
Net loss
 
$
(128,158
)
Changes in assets and liabilities:
       
Increase in accrued expenses
   
28,138
 
Net cash used in operating activities
   
(100,020
)
         
Cash Flows from Financing Activities
       
Proceeds from issuance of common stock
   
100,000
 
Advance from officers
   
100,000
 
Repayment of loan from officers
   
(64,088
)
Net cash provided by financing activities
   
135,912
 
         
Net increase in cash and cash equivalents
   
35,892
 
         
Cash and Cash Equivalents
       
Beginning
   
54,132
 
Ending
 
$
90,024
 
         
Supplemental Disclosure of Cash Flows
       
Cash paid during the year for:
       
Interest
 
$
-
 
         
Income taxes
 
$
-
 
 
 
The accompanying notes to financial statements are an integral part of these statements.
EOS INC.
NOTES TO FINANCIAL STATEMENTS
MARCH 31, 2016
(UNAUDITED)
NOTE 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting and in accordance with instructions for Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year.

Basis of Presentation and Organization

EOS Inc., a company in the developmental stage (the “Company”), was incorporated on April 3, 2015 in the State of Nevada. The Company has conducted limited business operations and had no revenues from operations since its inception. The Company‘s business plan is to market and distribute skin care products, including masks and serums.

Going Concern
 
These financial statements were prepared on the basis of accounting principles applicable to going concern, which assumes the realization of assets and discharge of liabilities in the normal course of business. As shown in the accompanying financial statements, the Company had accumulated deficits of $278,149 and $149,991 as of March 31, 2016 and December 31, 2015, respectively, and it had no revenue from operations.

The Company faces all the risks common to companies at development stage, including capitalization and uncertainty of funding sources, high initial expenditure levels, uncertain revenue streams, and difficulties in managing growth. The Company's losses raise substantial doubt about its ability to continue as a going concern. The Company's financial statements do not reflect any adjustments that might result from the outcome of this uncertainty.

The Company is currently addressing its liquidity issue by continually seeking additional funds through private placements of its securities and/or capital contributions and loans by Yu-Cheng Yang, its president and sole director. The Company believes its current and future plans enable it to continue as a going concern. The Company's ability to achieve these objectives cannot be determined at this time.

These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets. 
 
NOTE 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (CONTINUED)
and discharge its liabilities in other than the normal course of business and at amounts which may differ from those in the accompanying consolidated financial statements.
 
Use of Estimates
 
The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the amount of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those results.
 
Cash and Cash Equivalents
 
Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.
 
Net Income (loss) per Share
 
Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. At March 31, 2016, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. The deferred income tax assets were $0 as of both March 31, 2016 and December 31, 2015.
 
The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. At March 31, 2016, management considered that the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.
 
NOTE 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (CONTINUED)
Reclassifications
 
Certain classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.
 
Recent Accounting Pronouncements
 
The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its result of operations, financial position or cash flow.

Subsequent events

Management has evaluated subsequent events through April 28, 2016, the date which the financial statements were available to be issued. All subsequent events requiring recognition as of March 31, 2016 have been incorporated into these consolidated financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”

NOTE 2. ACCRUED EXPENSES

Accrued expenses consist of the following:
   
March 31,
2016
   
December 31,
2015
 
Accrued professional fees
 
$
28,138
   
$
-
 
   
$
28,138
   
$
-
 

NOTE 3. DUE TO RELATED PARTIES
 
The Company has advanced funds from its officer and shareholder for working capital purposes. As of March 31, 2016 and December 31, 2015, there were $185,912 and $150,000 advances outstanding, respectively. The Company has agreed that the outstanding balances bear 0% interest rate and are due upon demand after 30 days written notice by the officer and shareholder.

NOTE 4. INCOME TAXES
 
As of March 31, 2016, the Company had net operating loss carry forwards of approximately $278,149 that may be available to reduce future years’ taxable income through 2035. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.

The provision for Federal income tax consists of the following for the three months ended March 31, 2016
 
   
For the three-months ended March 31, 2016
 
Federal income tax benefit attributable to:
     
Current Operations
 
$
43,574
 
Less: valuation allowance
   
(43,574
)
Net provision for Federal income taxes
 
$
-
 

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following as of March 31, 2016 and December 31, 2015:

   
March 31,
2016
   
December 31,
2015
 
Deferred tax asset attributable to:
           
Net operating loss carryover
 
$
94,571
   
$
50,997
 
Less: valuation allowance
   
(94,571
)
   
(50,997
)
Net deferred tax asset
 
$
-
   
$
-
 

The difference between the effective rate reflected in the provision for income taxes on loss before taxes and the amounts determined by applying the applicable statutory U.S. tax rate are analyzed below:

   
For the three-month ended March 31, 2016
 
       
Statutory tax benefit
   
(34
)%
Nondeductible/nontaxable items
   
-
%
Change in deferred tax asset valuation allowance
   
34
%
Provision for income taxes
   
-
%
         
For the three months ended March 31, 2016, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.
 
NOTE 5. STOCKHOLDERS’ DEFICIT
 
From April 3, 2015 to December 31, 2015, the Company has issued 54,122,997 common stock shares at par value in a total amount of $54,123 from its shareholders.

On February 24, 2016, the Company has issued 10,000,000 shares of its $0.001 par value common stock shares at a purchase price of $0.01 per share in a total amount of $100,000 from fifteen shareholders.
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operation.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q, including this discussion and analysis by management, contains or incorporates forward-looking statements.   All statements other than statements of historical fact made in report are forward looking.  In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking statements.  These forward-looking statements can be identified by the use of words such as “believes,” “estimates,” “could,” “possibly,” “probably,” anticipates,” “projects,” “expects,” “may,” “will,” or “should” or other variations or similar words.  No assurances can be given that the future results anticipated by the forward-looking statements will be achieved.  Forward-looking statements reflect management’s current expectations and are inherently uncertain.  Our actual results may differ significantly from management’s expectations.

The following discussion and analysis should be read in conjunction with our financial statements, included herewith.  This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future.  Such discussion represents only the best present assessment of our management.

Three Months Ended March 31, 2016

Net revenue for the three months ended March 31, 2016, was $0.

General and administrative expenses for the three months ended March 31, 2016, were $128,158.

Our net loss was $(128,158) for the three months ended March 31, 2016.

Liquidity and Capital Resources

Cash and cash equivalents were $90,024 at March 31, 2016. Our total current assets were $90,024 at March 31, 2016. Our total current liabilities were $214,050 at March 31, 2016.

We had a negative working capital at March 31, 2016, of $(124,026), compared to negative working capital of $(95,868) at December 31, 2015.
Net cash used in operating activities during the three months ended March 31, 2016, was ($100,020).

Net cash provided by financing activities for the three months ended March 31, 2016, was $135,912, which was due to proceeds from sales of our common stock and an advance from our officer.

Net change in cash and cash equivalents was an increase of $35,892 for the three months ended March 31, 2016.

Inflation
 
Our opinion is that inflation has not had a material effect on our operations and is not expected to have any material effect on our operations.
Climate Change

Our opinion is that neither climate change, nor governmental regulations related to climate change, have had, or are expected to have, any material effect on our operations.

Item 3.    Quantitative and Qualitative Disclosures About Market Risk.

As a smaller reporting company, we are not required to provide this information.

Item 4.   Controls and Procedures.

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of end of the period covered by this report to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is (1) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure; and (2) recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission.

There was no change to our internal controls or in other factors that could affect these controls during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.   Legal Proceedings.
None.
Item 1A. Risk Factors.  

As a smaller reporting company, we are not required to provide this information.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.

None.
   
Item 3.   Defaults Upon Senior Securities.

None.
 
Item 4.   Mine Safety Disclosures.

Not applicable.

Item 5.   Other Information.

None.
 
Item 6.        Exhibits.

The following exhibits are filed as part of this quarterly report, pursuant to Item 601 of Regulation S-K.  All exhibits are attached hereto unless otherwise noted.

Exhibit Number
 
Description
     
3.1*
 
Articles of Incorporation
3.2*
 
Certificate of Amendment to Articles of Incorporation
3.3*
 
Bylaws
3.4**
 
Certificate of Correction of Articles of Incorporation
10.1*
 
Distribution Agreement dated May 1, 2015 between A.C. (USA) Inc. and the Company
31***
 
32***
 

* Included as an exhibit with that Registration Statement on Form S-1 filed with the SEC on September 10, 2015.
** Included as an exhibit with that Registration Statement on Form S-1/A filed with the SEC on October 21, 2015.
 
*** Filed herewith.
 
 
 
 
SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
EOS Inc.
 
 
 
 
Date: May 13, 2016
By:  
/s/ Yu Cheng Yang
 
Yu Cheng Yang
 
Principal Executive Officer, Principal Financial Officer,
President and Chairman of the Board
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12
EX-31 2 ex-31.htm EX 31
EXHIBIT 31
 
CERTIFICATION

I, Yu Cheng Yang, certify that:

1. I have reviewed this quarterly report on Form 10-Q of EOS Inc. (the “registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

May 13, 2016
 
/s/ Yu Cheng Yang
 
 
 
Yu Cheng Yang
Principal Executive Officer and Principal Financial Officer
 
 
 
 
EX-32 3 ex-32.htm EX 32
EXHIBIT 32
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of EOS Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company hereby certifies, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, to such officer’s knowledge that:

(i)  the Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (subject to the Company's position prevailing in regard to the remaining unresolved SEC comment, as more fully described in the Report); and

(ii)  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
 
May 13, 2016

/s/ Yu Cheng Yang
Principal Executive Officer and Principal Financial Officer
EX-101.INS 4 eoin-20160331.xml XBRL INSTANCE DOCUMENT 0001651958 2015-12-31 0001651958 us-gaap:CommonStockMember 2015-04-03 2015-12-31 0001651958 eoin:ShareholdersMember 2016-02-24 0001651958 eoin:ShareholdersMember 2016-02-01 2016-02-24 0001651958 2016-01-01 2016-03-31 0001651958 2016-03-31 0001651958 2016-05-10 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure eoin:Shareholder EOS INC. 0001651958 eoin --12-31 Smaller Reporting Company 64122997 10-Q 2016-03-31 false 2016 Q1 54132 90024 54132 90024 54132 90024 150000 185912 150000 214050 54123 64123 -149991 -278149 -95868 -24026 54132 90024 0.001 0.001 0.001 750000000 750000000 54122997 10000000 64122997 54122997 64122997 128158 -128158 -128158 -128158 58188931 -0.00 100000 100000 135912 35892 54123 100000 54122997 <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin-bottom: 12pt; font-weight: bold; text-align: left;">NOTE 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Basis of Presentation</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;) for interim financial reporting and in accordance with instructions for Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Basis of Presentation and Organization</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">EOS Inc., a company in the developmental stage (the &#8220;Company&#8221;), was incorporated on April 3, 2015 in the State of Nevada. The Company has conducted limited business operations and had no revenues from operations since its inception.&#160;<font style="font-size: 10pt; font-family: 'times new roman', times, serif;">The Company&#8216;s business plan is to market and distribute skin care products, including masks and serums.</font></div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Going Concern</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">These financial statements were prepared on the basis of accounting principles applicable to going concern, which assumes the realization of assets and discharge of liabilities in the normal course of business. As shown in the accompanying financial statements, the Company had accumulated deficits of $278,149 and $149,991 as of March 31, 2016 and December 31, 2015, respectively, and it had no revenue from operations.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company faces all the risks common to companies at development stage, including capitalization and uncertainty of funding sources, high initial expenditure levels, uncertain revenue streams, and difficulties in managing growth. The Company's losses raise substantial doubt about its ability to continue as a going concern. The Company's financial statements do not reflect any adjustments that might result from the outcome of this uncertainty.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company is currently addressing its liquidity issue by continually seeking additional funds through private placements of its securities and/or capital contributions and loans by Yu-Cheng Yang, its president and sole director. The Company believes its current and future plans enable it to continue as a going concern. The Company's ability to achieve these objectives cannot be determined at this time.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;"><font style="font-size: 10pt; font-family: 'times new roman', times, serif;">These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets.</font><font style="font-size: 10pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</font>and discharge its liabilities in other than the normal course of business and at amounts which may differ from those in the accompanying consolidated financial statements.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Use of Estimates</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the amount of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those results.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Cash and Cash Equivalents</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Net Income (loss) per Share</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. At March 31, 2016, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Income Taxes</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. The deferred income tax assets were $0 as of both March 31, 2016 and December 31, 2015.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company applied the provisions of ASC 740-10-50,&#160;&#8220;Accounting For Uncertainty In Income Taxes&#8221;, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company&#8217;s liability for income taxes. Any such adjustment could be material to the Company&#8217;s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. At March 31, 2016, management considered that the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin-bottom: 10pt; clear: both; margin-top: 10pt;" >Reclassifications&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Certain classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Recent Accounting Pronouncements</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its result of operations, financial position or cash flow.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: justify;">Subsequent events</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Management has evaluated subsequent events through April 28, 2016, the date which the financial statements were available to be issued. All subsequent events requiring recognition as of March 31, 2016 have been incorporated into these consolidated financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, &#8220;Subsequent Events.&#8221;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; font-weight: bold; text-align: justify;">NOTE 3. DUE TO RELATED PARTIES</div> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: justify;">&#160;</div> </div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company has advanced funds from its officer and shareholder for working capital purposes. As of March 31, 2016 and December 31, 2015, there were $185,912 and $150,000 advances outstanding, respectively. The Company has agreed that the outstanding balances bear 0% interest rate and are due upon demand after 30 days written notice by the officer and shareholder.</div> <div style="font: bold 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">NOTE 4. INCOME TAXES</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">As of March 31, 2016, the Company had net operating loss carry forwards of approximately $278,149 that may be available to reduce future years&#8217; taxable income through 2035. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.</div> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">The provision for Federal income tax consists of the following for the three months ended March 31, 2016</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <table style="width: 1742.22px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px; vertical-align: top;" valign="bottom">&#160;</td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;">For the three-months ended March 31, 2016</div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;">Federal income tax benefit attributable to:</div> </td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom" colspan="2">&#160;</td> <td style="text-align: left; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="width: 1533.33px; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt; margin-left: 12.6pt;">Current Operations</div> </td> <td style="width: 17.77px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">43,574</div> </td> <td style="width: 16.66px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="width: 1533.33px; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt; margin-left: 12.6pt;">Less: valuation allowance</div> </td> <td style="width: 17.77px; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">(43,574</div> </td> <td style="width: 16.66px; text-align: left; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="width: 1533.33px; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;">Net provision for Federal income taxes</div> </td> <td style="width: 17.77px; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</div> </td> <td style="width: 16.66px; text-align: left; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following as of March 31, 2016 and December 31, 2015:</div> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <table style="width: 1742.22px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;">March 31, 2016</div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;">December 31, 2015</div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;">Deferred tax asset attributable to:</div> </td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom" colspan="2">&#160;</td> <td style="text-align: left; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom" colspan="2">&#160;</td> <td style="text-align: left; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="width: 1324.44px; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt; margin-left: 12.6pt;">Net operating loss carryover</div> </td> <td style="width: 17.77px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 157.77px; text-align: right; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">94,571</div> </td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="width: 16.66px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 16.66px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">50,997</div> </td> <td style="width: 16.66px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="width: 1324.44px; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt; margin-left: 12.6pt;">Less: valuation allowance</div> </td> <td style="width: 17.77px; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 157.77px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">(94,571</div> </td> <td style="width: 17.77px; text-align: left; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">)</div> </td> <td style="width: 16.66px; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 16.66px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">(50,997</div> </td> <td style="width: 16.66px; text-align: left; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="width: 1324.44px; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;">Net deferred tax asset</div> </td> <td style="width: 17.77px; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 157.77px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</div> </td> <td style="width: 17.77px; text-align: left; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="width: 16.66px; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 16.66px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</div> </td> <td style="width: 16.66px; text-align: left; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">The difference between the effective rate reflected in the provision for income taxes on loss before taxes and the amounts determined by applying the applicable statutory U.S. tax rate are analyzed below:</div> <div style="font: 13.33px/normal 'times new roman', times, serif; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">&#160;</div> <table style="width: 1742.22px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px; vertical-align: middle;" valign="bottom">&#160;</td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: middle; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;">For the three-month ended March 31, 2016</div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: middle;" valign="bottom" colspan="2">&#160;</td> <td style="text-align: left; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="width: 1533.33px; vertical-align: middle; background-color: #cceeff;" valign="bottom"> <div style="text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;">Statutory tax benefit</div> </td> <td style="width: 17.77px; text-align: right; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">(34</div> </td> <td style="width: 16.66px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">)%</div> </td> </tr> <tr> <td style="width: 1533.33px; vertical-align: middle; background-color: #ffffff;" valign="bottom"> <div style="text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;">Nondeductible/nontaxable items</div> </td> <td style="width: 17.77px; text-align: right; vertical-align: bottom; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; background-color: #ffffff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</div> </td> <td style="width: 16.66px; text-align: left; vertical-align: bottom; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="width: 1533.33px; padding-bottom: 2px; vertical-align: middle; background-color: #cceeff;" valign="bottom"> <div style="text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;">Change in deferred tax asset valuation allowance</div> </td> <td style="width: 17.77px; text-align: right; padding-bottom: 2px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">34</div> </td> <td style="width: 16.66px; text-align: left; padding-bottom: 2px; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">%</div> </td> </tr> <tr style="height: 20px;"> <td style="width: 1533.33px; padding-bottom: 4px; vertical-align: middle; background-color: #ffffff;" valign="bottom"> <div style="text-align: left; text-indent: 11pt; font-family: 'times new roman', times, serif; font-size: 10pt;">Provision for income taxes</div> </td> <td style="width: 17.77px; text-align: right; padding-bottom: 4px; vertical-align: bottom; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 156.66px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #ffffff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</div> </td> <td style="width: 16.66px; text-align: left; padding-bottom: 4px; vertical-align: bottom; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">%</div> </td> </tr> <tr> <td style="width: 1533.33px; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: right; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="width: 17.77px; text-align: left; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="width: 156.66px; text-align: right; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="width: 16.66px; text-align: left; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; -webkit-text-stroke-width: 0px;">For the three months ended March 31, 2016, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; text-align: left;">NOTE 5. STOCKHOLDERS&#8217; DEFICIT</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">From April 3, 2015 to December 31, 2015, the Company has issued 54,122,997 common stock shares at par value in a total amount of $54,123 from its shareholders.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">On February 24, 2016, the Company has issued 10,000,000 shares of its $0.001 par value common stock shares at a purchase price of $0.01 per share in a total amount of $100,000 from fifteen shareholders.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Basis of Presentation</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;) for interim financial reporting and in accordance with instructions for Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Going Concern</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">These financial statements were prepared on the basis of accounting principles applicable to going concern, which assumes the realization of assets and discharge of liabilities in the normal course of business. As shown in the accompanying financial statements, the Company had accumulated deficits of $278,149 and $149,991 as of March 31, 2016 and December 31, 2015, respectively, and it had no revenue from operations.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company faces all the risks common to companies at development stage, including capitalization and uncertainty of funding sources, high initial expenditure levels, uncertain revenue streams, and difficulties in managing growth. The Company's losses raise substantial doubt about its ability to continue as a going concern. The Company's financial statements do not reflect any adjustments that might result from the outcome of this uncertainty.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company is currently addressing its liquidity issue by continually seeking additional funds through private placements of its securities and/or capital contributions and loans by Yu-Cheng Yang, its president and sole director. The Company believes its current and future plans enable it to continue as a going concern. The Company's ability to achieve these objectives cannot be determined at this time.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;"><font style="font-size: 10pt; font-family: 'times new roman', times, serif;">These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets.</font><font style="font-size: 10pt; font-family: 'times new roman', times, serif; font-weight: bold;">&#160;</font></div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">and discharge its liabilities in other than the normal course of business and at amounts which may differ from those in the accompanying consolidated financial statements.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Use of Estimates</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the amount of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those results.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Cash and Cash Equivalents</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Net Income (loss) per Share</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. At March 31, 2016, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Income Taxes</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. The deferred income tax assets were $0 as of both March 31, 2016 and December 31, 2015.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">The Company applied the provisions of ASC 740-10-50,&#160;&#8220;Accounting For Uncertainty In Income Taxes&#8221;, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company&#8217;s liability for income taxes. Any such adjustment could be material to the Company&#8217;s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. At March 31, 2016, management considered that the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: italic bold 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">Recent Accounting Pronouncements</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: left; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="font: 10pt/normal 'times new roman', times, serif; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its result of operations, financial position or cash flow.</div> 0.00 P30D 0.01 15 28138 28138 <div>&#160;</div> <table style="width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: middle; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000;" valign="bottom" colspan="2"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: center;">March 31, 2016</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: middle; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000;" valign="bottom" colspan="2"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: center;">December 31, 2015</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px; width: 1191px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: left;">Accrued professional fees</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: right; width: 142px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">28,138</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px; width: 15px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 4px; width: 1191px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: right; width: 142px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">28,138</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 15px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <table style="width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="padding-bottom: 2px; vertical-align: top;" valign="bottom"></td> <td style="padding-bottom: 2px; vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"> <div style="text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;">For the three-months ended March 31, 2016</div> </td> <td style="text-align: left; padding-bottom: 2px; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;">Federal income tax benefit attributable to:</div> </td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom" colspan="2">&#160;</td> <td style="text-align: left; vertical-align: bottom;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="width: 1379px; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt; margin-left: 12.6pt;">Current Operations</div> </td> <td style="width: 16px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 16px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 141px; text-align: right; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">43,574</div> </td> <td style="width: 15px; text-align: left; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="width: 1379px; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt; margin-left: 12.6pt;">Less: valuation allowance</div> </td> <td style="width: 16px; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 16px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="width: 141px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 2px; border-bottom-style: solid; background-color: #ffffff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">(43,574</div> </td> <td style="width: 15px; text-align: left; padding-bottom: 2px; vertical-align: bottom; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="width: 1379px; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom"> <div style="text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;">Net provision for Federal income taxes</div> </td> <td style="width: 16px; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="width: 16px; text-align: left; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">$</div> </td> <td style="width: 141px; text-align: right; vertical-align: bottom; border-bottom-color: #000000; border-bottom-width: 4px; border-bottom-style: double; background-color: #cceeff;" valign="bottom"> <div style="font-family: 'times new roman', times, serif; font-size: 10pt;">-</div> </td> <td style="width: 15px; text-align: left; padding-bottom: 4px; vertical-align: bottom; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <div>&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <table style="width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000;" valign="bottom" colspan="2"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: center;">March 31, 2016</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000;" valign="bottom" colspan="2"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: center;">December 31, 2015</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: left;">Deferred tax asset attributable to:</div> </td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom" colspan="2">&#160;</td> <td style="vertical-align: bottom; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom" colspan="2">&#160;</td> <td style="vertical-align: bottom; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: bottom; width: 1191px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: left; margin-left: 12.6pt;">Net operating loss carryover</div> </td> <td style="vertical-align: bottom; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; text-align: right; width: 142px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">94,571</div> </td> <td style="vertical-align: bottom; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; width: 15px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; text-align: right; width: 141px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">50,997</div> </td> <td style="vertical-align: bottom; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; width: 1191px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: left; margin-left: 12.6pt;">Less: valuation allowance</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: right; width: 142px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">(94,571</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">)</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; width: 15px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">(50,997</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 4px; width: 1191px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: left;">Net deferred tax asset</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: right; width: 142px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 15px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">$</div> </td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <div>&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <table style="width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: middle; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: middle; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000;" valign="bottom" colspan="2"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: center;">For the three-month ended March 31, 2016</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: middle;" valign="bottom">&#160;</td> <td style="vertical-align: bottom;" valign="bottom">&#160;</td> <td style="vertical-align: middle;" valign="bottom" colspan="2">&#160;</td> <td style="vertical-align: bottom; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: middle; width: 1379px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: justify;">Statutory tax benefit</div> </td> <td style="vertical-align: bottom; text-align: right; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right; width: 141px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">(34</div> </td> <td style="vertical-align: bottom; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom" nowrap="nowrap"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">)%</div> </td> </tr> <tr> <td style="vertical-align: middle; width: 1379px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: justify;">Nondeductible/nontaxable items</div> </td> <td style="vertical-align: bottom; text-align: right; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right; width: 141px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">-</div> </td> <td style="vertical-align: bottom; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">%</div> </td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px; width: 1379px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: justify;">Change in deferred tax asset valuation allowance</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">34</div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom" nowrap="nowrap"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">%</div> </td> </tr> <tr style="height: 20px;"> <td style="vertical-align: middle; padding-bottom: 4px; width: 1379px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: left; text-indent: 11pt;">Provision for income taxes</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">-</div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom" nowrap="nowrap"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;">%</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 1379px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right; width: 16px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: left; width: 16px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right; width: 141px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; text-align: left; width: 15px;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <div>&#160;</div> 43574 -43574 50997 94571 50997 94571 0.34 -0.34 278149 90000 28138 -100020 64088 <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; font-weight: bold; text-align: justify;"><font style="font-family: times new roman,times;">NOTE 2. ACCRUED EXPENSES</font></div> </div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;"><font style="font-family: times new roman,times;">Accrued expenses consist of the following:</font></div> <table style="width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; word-spacing: 0px; widows: 1; -webkit-text-stroke-width: 0px;" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: middle; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000;" valign="bottom" colspan="2"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: center;"><font style="font-family: times new roman,times;">March 31, 2016</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td> <td style="vertical-align: middle; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000;" valign="bottom" colspan="2"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: center;"><font style="font-family: times new roman,times;">December 31, 2015</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 2px; width: 1191px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif; text-align: left;"><font style="font-family: times new roman,times;">Accrued professional fees</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; width: 16px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">$</font></div> </td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: right; width: 142px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">28,138</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 16px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2px; width: 15px; background-color: #cceeff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">$</font></div> </td> <td style="vertical-align: bottom; border-bottom-width: 2px; border-bottom-style: solid; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #cceeff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">-</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 15px; background-color: #cceeff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> <tr> <td style="vertical-align: middle; padding-bottom: 4px; width: 1191px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 16px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">$</font></div> </td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: right; width: 142px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">28,138</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 16px; background-color: #ffffff;" valign="bottom" nowrap="nowrap">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 4px; width: 15px; background-color: #ffffff;" valign="bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">$</font></div> </td> <td style="vertical-align: bottom; border-bottom-width: 4px; border-bottom-style: double; border-bottom-color: #000000; text-align: right; width: 141px; background-color: #ffffff;" valign="bottom"> <div style="font-size: 10pt; font-family: 'times new roman', times, serif;"><font style="font-family: times new roman,times;">-</font></div> </td> <td style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 15px; background-color: #ffffff;" valign="bottom" nowrap="nowrap">&#160;</td> </tr> </table> <div>&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: left;">Reclassifications</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: left; text-indent: 36pt;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Certain classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-weight: bold; font-style: italic; text-align: justify;">Subsequent events</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-align: justify;">Management has evaluated subsequent events through April 28, 2016, the date which the financial statements were available to be issued. All subsequent events requiring recognition as of March 31, 2016 have been incorporated into these consolidated financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, &#8220;Subsequent Events.&#8221;</div> <div style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">&#160;</div> EX-101.SCH 5 eoin-20160331.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - Document Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 003 - Statement - BALANCE SHEETS (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - STATEMENT OF CASH FLOWS (UNAUDITED) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - ACCRUED EXPENSES link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - DUE TO RELATED PARTIES link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - INCOME TAXES link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - STOCKHOLDERS' DEFICIT link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - ACCRUED EXPENSES (Tables) link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - ACCRUED EXPENSES (Details) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - DUE TO RELATED PARTIES (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - INCOME TAXES (Details) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - INCOME TAXES (Details 1) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - INCOME TAXES (Details 2) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - INCOME TAXES (Details Textuals) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - STOCKHOLDERS' DEFICIT (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 eoin-20160331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 eoin-20160331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 eoin-20160331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 9 eoin-20160331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.4.0.3
Document Entity Information - shares
3 Months Ended
Mar. 31, 2016
May. 10, 2016
Document And Entity Information [Abstract]    
Entity Registrant Name EOS INC.  
Entity Central Index Key 0001651958  
Trading Symbol eoin  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   64,122,997
Document Type 10-Q  
Document Period End Date Mar. 31, 2016  
Amendment Flag false  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q1  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
BALANCE SHEETS - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current Assets    
Cash and cash equivalents $ 90,024 $ 54,132
Total current assets 90,024 54,132
Total Assets 90,024 54,132
Current Liabilities    
Accrued expenses 28,138  
Due to related parties 185,912 150,000
Total current liabilities 214,050 150,000
Stockholders' Deficit    
Common stock, $0.001 par value; 750,000,000 shares authorized, 64,122,997 and 54,122,997 shares issued and outstanding, respectively 64,123 54,123
Additional paid-in capital 90,000  
Accumulated deficits (278,149) (149,991)
Total stockholders' deficit (24,026) (95,868)
Total Liabilities and Stockholders' Deficit $ 90,024 $ 54,132
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.4.0.3
BALANCE SHEETS (Parentheticals) - $ / shares
Mar. 31, 2016
Dec. 31, 2015
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 750,000,000 750,000,000
Common stock shares issued 64,122,997 54,122,997
Common stock, shares outstanding 64,122,997 54,122,997
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
STATEMENTS OF OPERATIONS (UNAUDITED)
3 Months Ended
Mar. 31, 2016
USD ($)
$ / shares
shares
Income Statement [Abstract]  
Net revenue
General and administrative expenses $ 128,158
Loss from operations (128,158)
Loss before income taxes $ (128,158)
Provision for income taxes expense
Net loss $ (128,158)
Weighted average number of shares outstanding:  
Basic and diluted (in shares) | shares 58,188,931
Net loss per share:  
Basic and diluted (in dollars per share) | $ / shares $ (0.00)
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
STATEMENT OF CASH FLOWS (UNAUDITED)
3 Months Ended
Mar. 31, 2016
USD ($)
Cash Flows from Operating Activities  
Net loss $ (128,158)
Changes in assets and liabilities:  
Increase in accrued expenses 28,138
Net cash used in operating activities (100,020)
Cash Flows from Financing Activities  
Proceeds from issuance of common stock 100,000
Advance from officers 100,000
Repayment of loan from officers (64,088)
Net cash provided by financing activities 135,912
Net increase in cash and cash equivalents 35,892
Cash and Cash Equivalents  
Beginning 54,132
Ending $ 90,024
Cash paid during the year for:  
Interest
Income taxes
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2016
Nature Of Operations And Summary Of Accounting Policies [Abstract]  
NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES
NOTE 1. NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting and in accordance with instructions for Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year.
 
Basis of Presentation and Organization
EOS Inc., a company in the developmental stage (the “Company”), was incorporated on April 3, 2015 in the State of Nevada. The Company has conducted limited business operations and had no revenues from operations since its inception. The Company‘s business plan is to market and distribute skin care products, including masks and serums.
 
Going Concern
 
These financial statements were prepared on the basis of accounting principles applicable to going concern, which assumes the realization of assets and discharge of liabilities in the normal course of business. As shown in the accompanying financial statements, the Company had accumulated deficits of $278,149 and $149,991 as of March 31, 2016 and December 31, 2015, respectively, and it had no revenue from operations.
The Company faces all the risks common to companies at development stage, including capitalization and uncertainty of funding sources, high initial expenditure levels, uncertain revenue streams, and difficulties in managing growth. The Company's losses raise substantial doubt about its ability to continue as a going concern. The Company's financial statements do not reflect any adjustments that might result from the outcome of this uncertainty.
The Company is currently addressing its liquidity issue by continually seeking additional funds through private placements of its securities and/or capital contributions and loans by Yu-Cheng Yang, its president and sole director. The Company believes its current and future plans enable it to continue as a going concern. The Company's ability to achieve these objectives cannot be determined at this time.
 
These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets. and discharge its liabilities in other than the normal course of business and at amounts which may differ from those in the accompanying consolidated financial statements.
 
Use of Estimates
 
The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the amount of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those results.
 
Cash and Cash Equivalents
 
Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.
 
Net Income (loss) per Share
 
Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. At March 31, 2016, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented.
 
Income Taxes
 
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. The deferred income tax assets were $0 as of both March 31, 2016 and December 31, 2015.
 
The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. At March 31, 2016, management considered that the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.
Reclassifications 
Certain classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.
 
Recent Accounting Pronouncements
 
The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its result of operations, financial position or cash flow.
 
Subsequent events
 
Management has evaluated subsequent events through April 28, 2016, the date which the financial statements were available to be issued. All subsequent events requiring recognition as of March 31, 2016 have been incorporated into these consolidated financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
ACCRUED EXPENSES
3 Months Ended
Mar. 31, 2016
Accrued Liabilities [Abstract]  
ACCRUED EXPENSES
NOTE 2. ACCRUED EXPENSES
 
Accrued expenses consist of the following:
   
March 31, 2016
   
December 31, 2015
 
Accrued professional fees
 
$
28,138
   
$
-
 
   
$
28,138
   
$
-
 
 
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
DUE TO RELATED PARTIES
3 Months Ended
Mar. 31, 2016
Related Party Transactions [Abstract]  
DUE TO RELATED PARTIES
NOTE 3. DUE TO RELATED PARTIES
 
The Company has advanced funds from its officer and shareholder for working capital purposes. As of March 31, 2016 and December 31, 2015, there were $185,912 and $150,000 advances outstanding, respectively. The Company has agreed that the outstanding balances bear 0% interest rate and are due upon demand after 30 days written notice by the officer and shareholder.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
INCOME TAXES
3 Months Ended
Mar. 31, 2016
Income Tax Disclosure [Abstract]  
INCOME TAXES
NOTE 4. INCOME TAXES
 
As of March 31, 2016, the Company had net operating loss carry forwards of approximately $278,149 that may be available to reduce future years’ taxable income through 2035. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.
 
The provision for Federal income tax consists of the following for the three months ended March 31, 2016
 
   
For the three-months ended March 31, 2016
 
Federal income tax benefit attributable to:
     
Current Operations
 
$
43,574
 
Less: valuation allowance
   
(43,574
)
Net provision for Federal income taxes
 
$
-
 
 
The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities consist of the following as of March 31, 2016 and December 31, 2015:
 
   
March 31, 2016
   
December 31, 2015
 
Deferred tax asset attributable to:
           
Net operating loss carryover
 
$
94,571
   
$
50,997
 
Less: valuation allowance
   
(94,571
)
   
(50,997
)
Net deferred tax asset
 
$
-
   
$
-
 
 
The difference between the effective rate reflected in the provision for income taxes on loss before taxes and the amounts determined by applying the applicable statutory U.S. tax rate are analyzed below:
 
   
For the three-month ended March 31, 2016
 
       
Statutory tax benefit
   
(34
)%
Nondeductible/nontaxable items
   
-
%
Change in deferred tax asset valuation allowance
   
34
%
Provision for income taxes
   
-
%
         
For the three months ended March 31, 2016, the Company had no unrecognized tax benefits and related interest and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
STOCKHOLDERS' DEFICIT
3 Months Ended
Mar. 31, 2016
Equity [Abstract]  
STOCKHOLDERS' DEFICIT
NOTE 5. STOCKHOLDERS’ DEFICIT
 
From April 3, 2015 to December 31, 2015, the Company has issued 54,122,997 common stock shares at par value in a total amount of $54,123 from its shareholders.
 
On February 24, 2016, the Company has issued 10,000,000 shares of its $0.001 par value common stock shares at a purchase price of $0.01 per share in a total amount of $100,000 from fifteen shareholders.
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2016
Nature Of Operations And Summary Of Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial reporting and in accordance with instructions for Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods presented. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the full year.
Going Concern
Going Concern
 
These financial statements were prepared on the basis of accounting principles applicable to going concern, which assumes the realization of assets and discharge of liabilities in the normal course of business. As shown in the accompanying financial statements, the Company had accumulated deficits of $278,149 and $149,991 as of March 31, 2016 and December 31, 2015, respectively, and it had no revenue from operations.
 
The Company faces all the risks common to companies at development stage, including capitalization and uncertainty of funding sources, high initial expenditure levels, uncertain revenue streams, and difficulties in managing growth. The Company's losses raise substantial doubt about its ability to continue as a going concern. The Company's financial statements do not reflect any adjustments that might result from the outcome of this uncertainty.
 
The Company is currently addressing its liquidity issue by continually seeking additional funds through private placements of its securities and/or capital contributions and loans by Yu-Cheng Yang, its president and sole director. The Company believes its current and future plans enable it to continue as a going concern. The Company's ability to achieve these objectives cannot be determined at this time.
 
These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets. 
 
and discharge its liabilities in other than the normal course of business and at amounts which may differ from those in the accompanying consolidated financial statements.
Use of Estimates
Use of Estimates
 
The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the amount of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those results.
Cash and cash equivalents
Cash and Cash Equivalents
 
Cash and cash equivalents include cash and all highly liquid instruments with original maturities of three months or less.
Net Income (loss) per Share
Net Income (loss) per Share
 
Basic income (loss) per share is computed by dividing net income by weighted average number of shares of common stock outstanding during each period. Diluted income per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during each period. At March 31, 2016, the Company does not have any outstanding common stock equivalents; therefore, a separate computation of diluted loss per share is not presented.
Income Taxes
Income Taxes
 
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. The deferred income tax assets were $0 as of both March 31, 2016 and December 31, 2015.
 
The Company applied the provisions of ASC 740-10-50, “Accounting For Uncertainty In Income Taxes”, which provides clarification related to the process associated with accounting for uncertain tax positions recognized in our financial statements. Audit periods remain open for review until the statute of limitations has passed. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the Company’s liability for income taxes. Any such adjustment could be material to the Company’s results of operations for any given quarterly or annual period based, in part, upon the results of operations for the given period. At March 31, 2016, management considered that the Company had no uncertain tax positions, and will continue to evaluate for uncertain positions in the future.
 
Reclassifications
Reclassifications
 
Certain classifications have been made to the prior year financial statements to conform to the current year presentation. The reclassification had no impact on previously reported net loss or accumulated deficit.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
 
The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on its result of operations, financial position or cash flow.
Subsequent events
Subsequent events
 
Management has evaluated subsequent events through April 28, 2016, the date which the financial statements were available to be issued. All subsequent events requiring recognition as of March 31, 2016 have been incorporated into these consolidated financial statements and there are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”
 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
ACCRUED EXPENSES (Tables)
3 Months Ended
Mar. 31, 2016
Accrued Liabilities [Abstract]  
Schedule of Accrued expenses
 
   
March 31, 2016
   
December 31, 2015
 
Accrued professional fees
 
$
28,138
   
$
-
 
   
$
28,138
   
$
-
 
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
INCOME TAXES (Tables)
3 Months Ended
Mar. 31, 2016
Income Tax Disclosure [Abstract]  
Schedule of provision for Federal income tax
 
For the three-months ended March 31, 2016
 
Federal income tax benefit attributable to:
     
Current Operations
 
$
43,574
 
Less: valuation allowance
   
(43,574
)
Net provision for Federal income taxes
 
$
-
 
 
Schedule of deferred tax assets and liabilities
 
   
March 31, 2016
   
December 31, 2015
 
Deferred tax asset attributable to:
           
Net operating loss carryover
 
$
94,571
   
$
50,997
 
Less: valuation allowance
   
(94,571
)
   
(50,997
)
Net deferred tax asset
 
$
-
   
$
-
 
 
Schedule of effective income tax rate
 
   
For the three-month ended March 31, 2016
 
       
Statutory tax benefit
   
(34
)%
Nondeductible/nontaxable items
   
-
%
Change in deferred tax asset valuation allowance
   
34
%
Provision for income taxes
   
-
%
         
 
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Detail Textuals) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Nature Of Operations And Summary Of Accounting Policies [Abstract]    
Accumulated deficits $ (278,149) $ (149,991)
Deferred income tax assets
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.4.0.3
ACCRUED EXPENSES (Details) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Payables and Accruals [Abstract]    
Accrued professional fees $ 28,138
Accrued expenses $ 28,138  
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.4.0.3
DUE TO RELATED PARTIES (Detail Textuals) - USD ($)
3 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Related Party Transactions [Abstract]    
Advances outstanding of officer and shareholder $ 185,912 $ 150,000
Interest rate of outstanding balances 0.00%  
Due of written notice by officer and shareholder 30 days  
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.4.0.3
INCOME TAXES (Details)
3 Months Ended
Mar. 31, 2016
USD ($)
Federal income tax benefit attributable to:  
Current Operations $ 43,574
Less: valuation allowance $ (43,574)
Net provision for Federal income taxes
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.4.0.3
INCOME TAXES (Details 1) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Deferred tax asset attributable to:    
Net operating loss carryover $ 94,571 $ 50,997
Deferred Tax Assets, Valuation Allowance $ (94,571) $ (50,997)
Net deferred tax asset
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.4.0.3
INCOME TAXES (Details 2)
3 Months Ended
Mar. 31, 2016
Income Tax Disclosure [Abstract]  
Statutory tax benefit (34.00%)
Nondeductible/nontaxable items
Change in deferred tax asset valuation allowance 34.00%
Provision for income taxes
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.4.0.3
INCOME TAXES (Details Textuals)
Mar. 31, 2016
USD ($)
Income Tax Disclosure [Abstract]  
Operating Loss Carryforwards $ 278,149
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3
STOCKHOLDERS' DEFICIT (Detail Textuals)
1 Months Ended 9 Months Ended
Feb. 24, 2016
USD ($)
Shareholder
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Mar. 31, 2016
$ / shares
shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Common Stock, Shares, Issued | shares   54,122,997 64,122,997
Common stock, par value (in dollars per share) | $ / shares   $ 0.001 $ 0.001
Shareholders      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Common stock issuance | $ $ 100,000    
Common Stock, Shares, Issued | shares 10,000,000    
Common stock, par value (in dollars per share) | $ / shares $ 0.001    
Shares issued, price per share | $ / shares $ 0.01    
Number of shareholders | Shareholder 15    
Common Stock      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Common stock issuance (in shares) | shares   54,122,997  
Common stock issuance | $   $ 54,123  
EXCEL 31 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 33 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 35 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 7 78 1 false 2 0 false 5 false false R1.htm 001 - Document - Document Entity Information Sheet http://www.eosinc.com/role/DocumentEntityInformation Document Entity Information Cover 1 false false R2.htm 002 - Statement - BALANCE SHEETS Sheet http://www.eosinc.com/role/Balancesheets BALANCE SHEETS Statements 2 false false R3.htm 003 - Statement - BALANCE SHEETS (Parentheticals) Sheet http://www.eosinc.com/role/Balancesheetsparentheticals BALANCE SHEETS (Parentheticals) Statements 3 false false R4.htm 004 - Statement - STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.eosinc.com/role/Statementsofoperations STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 005 - Statement - STATEMENT OF CASH FLOWS (UNAUDITED) Sheet http://www.eosinc.com/role/StatementOfCashFlowsUnaudited STATEMENT OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 006 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES Sheet http://www.eosinc.com/role/NatureOfOperationsAndSummaryOfAccountingPolicies NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES Notes 6 false false R7.htm 007 - Disclosure - ACCRUED EXPENSES Sheet http://www.eosinc.com/role/AccruedExpenses ACCRUED EXPENSES Notes 7 false false R8.htm 008 - Disclosure - DUE TO RELATED PARTIES Sheet http://www.eosinc.com/role/DueToRelatedParties DUE TO RELATED PARTIES Notes 8 false false R9.htm 009 - Disclosure - INCOME TAXES Sheet http://www.eosinc.com/role/IncomeTaxes INCOME TAXES Notes 9 false false R10.htm 010 - Disclosure - STOCKHOLDERS' DEFICIT Sheet http://www.eosinc.com/role/StockholdersDeficit STOCKHOLDERS' DEFICIT Notes 10 false false R11.htm 011 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Policies) Sheet http://www.eosinc.com/role/NATUREOFOPERATIONSANDSUMMARYOFACCOUNTINGPOLICIESPolicies NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Policies) Policies 11 false false R12.htm 012 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://www.eosinc.com/role/ACCRUEDEXPENSESTables ACCRUED EXPENSES (Tables) Tables http://www.eosinc.com/role/AccruedExpenses 12 false false R13.htm 013 - Disclosure - INCOME TAXES (Tables) Sheet http://www.eosinc.com/role/INCOMETAXESTables INCOME TAXES (Tables) Tables http://www.eosinc.com/role/IncomeTaxes 13 false false R14.htm 014 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Detail Textuals) Sheet http://www.eosinc.com/role/NATUREOFOPERATIONSANDSUMMARYOFACCOUNTINGPOLICIESDetails NATURE OF OPERATIONS AND SUMMARY OF ACCOUNTING POLICIES (Detail Textuals) Details http://www.eosinc.com/role/NATUREOFOPERATIONSANDSUMMARYOFACCOUNTINGPOLICIESPolicies 14 false false R15.htm 015 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://www.eosinc.com/role/ACCRUEDEXPENSESDetails ACCRUED EXPENSES (Details) Details http://www.eosinc.com/role/ACCRUEDEXPENSESTables 15 false false R16.htm 016 - Disclosure - DUE TO RELATED PARTIES (Detail Textuals) Sheet http://www.eosinc.com/role/DUETORELATEDPARTIESDetails DUE TO RELATED PARTIES (Detail Textuals) Details http://www.eosinc.com/role/DueToRelatedParties 16 false false R17.htm 017 - Disclosure - INCOME TAXES (Details) Sheet http://www.eosinc.com/role/INCOMETAXESDetails INCOME TAXES (Details) Details http://www.eosinc.com/role/INCOMETAXESTables 17 false false R18.htm 018 - Disclosure - INCOME TAXES (Details 1) Sheet http://www.eosinc.com/role/INCOMETAXESDetails1 INCOME TAXES (Details 1) Details http://www.eosinc.com/role/INCOMETAXESTables 18 false false R19.htm 019 - Disclosure - INCOME TAXES (Details 2) Sheet http://www.eosinc.com/role/INCOMETAXESDetails2 INCOME TAXES (Details 2) Details http://www.eosinc.com/role/INCOMETAXESTables 19 false false R20.htm 020 - Disclosure - INCOME TAXES (Details Textuals) Sheet http://www.eosinc.com/role/IncomeTaxesDetailsTextuals INCOME TAXES (Details Textuals) Details http://www.eosinc.com/role/INCOMETAXESTables 20 false false R21.htm 021 - Disclosure - STOCKHOLDERS' DEFICIT (Detail Textuals) Sheet http://www.eosinc.com/role/STOCKHOLDERSDEFICITDetails STOCKHOLDERS' DEFICIT (Detail Textuals) Details http://www.eosinc.com/role/StockholdersDeficit 21 false false All Reports Book All Reports eoin-20160331.xml eoin-20160331.xsd eoin-20160331_cal.xml eoin-20160331_def.xml eoin-20160331_lab.xml eoin-20160331_pre.xml true true ZIP 37 0001640334-16-001063-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001640334-16-001063-xbrl.zip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end